Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5NQP

Structure of a fHbp(V1.4):PorA(P1.16) chimera. Fusion at fHbp position 151.

Summary for 5NQP
Entry DOI10.2210/pdb5nqp/pdb
DescriptorFactor H binding protein variant B16_001,Major outer membrane protein P.IA,Factor H binding protein variant B16_001, SULFATE ION, 1,2-ETHANEDIOL, ... (5 entities in total)
Functional Keywordsmeningitis, vaccine, complement, chimeric, immune system
Biological sourceNeisseria meningitidis
More
Total number of polymer chains3
Total formula weight89413.97
Authors
Johnson, S.,Hollingshead, S.,Lea, S.M.,Tang, C.M. (deposition date: 2017-04-20, release date: 2018-02-28, Last modification date: 2024-01-17)
Primary citationHollingshead, S.,Jongerius, I.,Exley, R.M.,Johnson, S.,Lea, S.M.,Tang, C.M.
Structure-based design of chimeric antigens for multivalent protein vaccines.
Nat Commun, 9:1051-1051, 2018
Cited by
PubMed Abstract: There is an urgent need to develop vaccines against pathogenic bacteria. However, this is often hindered by antigenic diversity and difficulties encountered manufacturing membrane proteins. Here we show how to use structure-based design to develop chimeric antigens (ChAs) for subunit vaccines. ChAs are generated against serogroup B Neisseria meningitidis (MenB), the predominant cause of meningococcal disease in wealthy countries. MenB ChAs exploit factor H binding protein (fHbp) as a molecular scaffold to display the immunogenic VR2 epitope from the integral membrane protein PorA. Structural analyses demonstrate fHbp is correctly folded and the PorA VR2 epitope adopts an immunogenic conformation. In mice, immunisation with ChAs generates fHbp and PorA antibodies that recognise the antigens expressed by clinical MenB isolates; these antibody responses correlate with protection against meningococcal disease. Application of ChAs is therefore a potentially powerful approach to develop multivalent subunit vaccines, which can be tailored to circumvent pathogen diversity.
PubMed: 29535307
DOI: 10.1038/s41467-018-03146-7
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.86 Å)
Structure validation

231029

건을2025-02-05부터공개중

PDB statisticsPDBj update infoContact PDBjnumon